Kathryn Lancaster to Opioid-Related Disorders
This is a "connection" page, showing publications Kathryn Lancaster has written about Opioid-Related Disorders.
Connection Strength
0.638
-
Kiriazova T, Go VF, Hershow RB, Hamilton EL, Sarasvita R, Bui Q, Lancaster KE, Dumchev K, Hoffman IF, Miller WC, Latkin CA. Perspectives of clients and providers on factors influencing opioid agonist treatment uptake among HIV-positive people who use drugs in Indonesia, Ukraine, and Vietnam: HPTN 074 study. Harm Reduct J. 2020 Oct 01; 17(1):69.
Score: 0.173
-
Richard EL, Schalkoff CA, Piscalko HM, Brook DL, Sibley AL, Lancaster KE, Miller WC, Go VF. "You are not clean until you're not on anything": Perceptions of medication-assisted treatment in rural Appalachia. Int J Drug Policy. 2020 Nov; 85:102704.
Score: 0.166
-
Schalkoff CA, Lancaster KE, Gaynes BN, Wang V, Pence BW, Miller WC, Go VF. The opioid and related drug epidemics in rural Appalachia: A systematic review of populations affected, risk factors, and infectious diseases. Subst Abus. 2020; 41(1):35-69.
Score: 0.160
-
Blackburn NA, Lancaster KE, Ha TV, Latkin CA, Miller WC, Frangakis C, Chu VA, Sripaipan T, Quan VM, Minh NL, Vu PT, Go VF. Characteristics of persons who inject drugs and who witness opioid overdoses in Vietnam: a cross-sectional analysis to inform future overdose prevention programs. Harm Reduct J. 2017 Sep 07; 14(1):62.
Score: 0.140